VELOXIS PHARMACEUTICALS A/S

The purpose of this study is to compare the effectiveness and safety of a new drug called LCP-Tacro™ to Prograf for preventing rejection in kidney transplant subjects when used in combination with MMF and corticosteroids, standard of care immunosuppressants beginning in the period immediately following kidney transplant.